Gregory J Pacofsky

Title: Gregory J Pacofsky: Innovator in Delta-Opioid Receptor Modulation

Introduction

Gregory J Pacofsky is a notable inventor based in King of Prussia, PA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate delta-opioid receptors. With a total of 2 patents to his name, his work is paving the way for advancements in pain management and treatment of various disorders.

Latest Patents

Pacofsky's latest patents focus on 6-membered aza-heterocyclic compounds that contain delta-opioid receptor modulating properties. These patents describe methods for using and making these compounds, which are aimed at treating conditions such as pain, migraines, headaches, depression, Parkinson's Disease, anxiety, and overactive bladder. The embodiments outlined in his patents include pharmaceutically acceptable salts and compositions that can effectively modulate the activity of delta-opioid receptors.

Career Highlights

Gregory J Pacofsky is currently associated with Trevena, Inc., a company that specializes in developing innovative therapies for central nervous system disorders. His work at Trevena has been instrumental in advancing the understanding and application of delta-opioid receptor modulation in clinical settings.

Collaborations

Throughout his career, Pacofsky has collaborated with esteemed colleagues such as Dennis Shinji Yamashita and Guodong Liu. These collaborations have contributed to the successful development of his patented compounds and have enhanced the research efforts within the field.

Conclusion

Gregory J Pacofsky's innovative work in the realm of delta-opioid receptor modulation showcases his commitment to improving therapeutic options for patients. His contributions are significant in the ongoing quest for effective treatments for various medical conditions.